In a partnership with CN-Bio, Dr. Yassen Abbas, Senior Scientist, highlighted the effectiveness of connected liver tissue with RepliGut® Planar-Jejunum in determining how the intestine impacts drug bioavailability and disposition. The use of an intestinal barrier model for drug development was key in their research. The team presented their researchfindings in a poster in June of 2023.